Table 1.

Characteristics of CLL patients and control subjects



Sweden

Denmark
Variable
Patients
Control subjects
Patients
Control subjects
Total number   5927   11 796   1837   4862  
Age in y at CLL diagnosis, median (interquartile range)   69 (61-76)   NA   62 (54-69)   NA  
Age group at CLL diagnosis, n (%)     
Young-adult onset CLL, 50 years or younger   380 (6)   761 (7)   301 (16)   1016 (21)  
Midlife onset CLL, 51-70 years   2904 (49)   5786 (49)   1180 (64)   3208 (66)  
Late onset CLL, older than 70 years   2643 (45)   5249 (44)   356 (20)   638 (13)  
Sex, n (%)     
Male   3854 (65)   7660 (65)   1287 (70)   3403 (70)  
Female   2073 (35)   4136 (35)   550 (30)   1459 (30)  
Year of CLL diagnosis, median (interquartile range)   1985 (1977-1993)   NA   1990 (1984-1994)   NA  
First-degree relatives, n (mean no. per proband)     
Parents   1101 (0.2)   2200 (0.2)   121 (0.1)   414 (0.1)  
Siblings   930 (0.2)   1870 (0.2)   80 (0.1)   218 (0.1)  
Offspring
 
12 340 (2.1)
 
24 873 (2.1)
 
3419 (1.9)
 
9813 (2.1)
 


Sweden

Denmark
Variable
Patients
Control subjects
Patients
Control subjects
Total number   5927   11 796   1837   4862  
Age in y at CLL diagnosis, median (interquartile range)   69 (61-76)   NA   62 (54-69)   NA  
Age group at CLL diagnosis, n (%)     
Young-adult onset CLL, 50 years or younger   380 (6)   761 (7)   301 (16)   1016 (21)  
Midlife onset CLL, 51-70 years   2904 (49)   5786 (49)   1180 (64)   3208 (66)  
Late onset CLL, older than 70 years   2643 (45)   5249 (44)   356 (20)   638 (13)  
Sex, n (%)     
Male   3854 (65)   7660 (65)   1287 (70)   3403 (70)  
Female   2073 (35)   4136 (35)   550 (30)   1459 (30)  
Year of CLL diagnosis, median (interquartile range)   1985 (1977-1993)   NA   1990 (1984-1994)   NA  
First-degree relatives, n (mean no. per proband)     
Parents   1101 (0.2)   2200 (0.2)   121 (0.1)   414 (0.1)  
Siblings   930 (0.2)   1870 (0.2)   80 (0.1)   218 (0.1)  
Offspring
 
12 340 (2.1)
 
24 873 (2.1)
 
3419 (1.9)
 
9813 (2.1)
 

CLL indicates chronic lymphocytic leukemia; NA, not applicable.

Close Modal

or Create an Account

Close Modal
Close Modal